Page last updated: 2024-10-29

iofetamine and Antiphospholipid Syndrome

iofetamine has been researched along with Antiphospholipid Syndrome in 2 studies

Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.

Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, T2
Nanbu, I1
Tohyama, J1
Ohba, S1
Morita, A1

Other Studies

2 other studies available for iofetamine and Antiphospholipid Syndrome

ArticleYear
[Evaluation of cerebral perfusion imaging with N-isopropyl-p-[123I]iodoamphetamine (IMP) in the cases of antiphospholipid syndrome].
    Kaku igaku. The Japanese journal of nuclear medicine, 1995, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Amphetamines; Antiphospholipid Syndrome; Brain; Cerebrovascular Circulation; Fema

1995
[Improvement of cerebral perfusion with argatroban in a patient with antiphospholipid syndrome].
    Ryumachi. [Rheumatism], 2000, Volume: 40, Issue:5

    Topics: Adult; Antiphospholipid Syndrome; Antithrombins; Arginine; Cerebrovascular Circulation; Female; Huma

2000